XBiotech
XBIT
$7.87
Share price
-4.14%
Change (1 day)
157.19%
Change (1 year)
Categories
XBiotech (XBIT) - Cash on Hand
Cash on Hand as of December 2023 : $0.20 B
According to XBiotech's latest financial reports the company has $0.20 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
XBiotech - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.21 B | -8.23% |
| 2021-12-31 | $0.23 B | -0.16% |
| 2020-12-31 | $0.23 B | -66.78% |
| 2019-12-31 | $0.71 B | 4416.17% |
| 2018-12-31 | $15.82 M | -50.19% |
| 2017-12-31 | $31.76 M | -7.45% |
| 2016-12-31 | $34.32 M | -62.3% |
| 2015-12-31 | $91.05 M | 58.82% |
| 2014-12-31 | $57.32 M | 691.4% |
| 2013-12-31 | $7.24 M | 73.84% |
| 2012-12-31 | $4.16 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 uniQure QURE | $0.61 B | 208.91% | 🇳🇱 Netherlands |
 Calithera Biosciences
CALA | $25.45 M | -87.28% | 🇺🇸 USA |
 Enzo Biochem ENZ | $60.24 M | -69.88% | 🇺🇸 USA |